loader
Please Wait
Applying Filters...

Australian Register of Therapeutic Goods list of Approved Drug Products containing NCGC00024584-03. Original Data : Therapeutic Goods Administration Website

Menu
$ API Ref.Price (USD/KG) : 14,922Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Sandoz Pty Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

bromocriptine

Brand Name : Parlodel

Dosage Form : tablet

Dosage Strength : 2.5 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

02

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

bromocriptine

Brand Name : Parlodel

Dosage Form : tablet

Dosage Strength : 2.5 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

03

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

bromocriptine

Brand Name : Parlodel

Dosage Form : tablet

Dosage Strength : 2.5 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

04

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

bromocriptine

Brand Name : Parlodel

Dosage Form : tablet

Dosage Strength : 2.5 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

bromocriptine

Brand Name : Parlodel

Dosage Form : tablet

Dosage Strength : 2.5 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank